AstraZeneca (LSE:AZN) Accounts Payable & Accrued Expense : £16,787 Mil (As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is AstraZeneca Accounts Payable & Accrued Expense?

AstraZeneca's quarterly accounts payable & accrued expense declined from Sep. 2023 (£17,538 Mil) to Dec. 2023 (£6,022 Mil) but then increased from Dec. 2023 (£6,022 Mil) to Mar. 2024 (£16,787 Mil).

AstraZeneca's annual accounts payable & accrued expense increased from Dec. 2021 (£4,405 Mil) to Dec. 2022 (£4,795 Mil) and increased from Dec. 2022 (£4,795 Mil) to Dec. 2023 (£6,022 Mil).

AstraZeneca Accounts Payable & Accrued Expense Historical Data

The historical data trend for AstraZeneca's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Accounts Payable & Accrued Expense Chart

AstraZeneca Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

4,690.92

4,207.32

4,405.22

4,795.46

6,022.17

AstraZeneca Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															16,820.31	16,582.90	17,537.64	6,022.17	16,786.71

AstraZeneca Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

AstraZeneca (LSE:AZN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (LSE:AZN) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

AZNCF:USA AZN:USA AZN:Sweden AZNN:Mexico AZNl:UK ZEGA:Germany ZEG:Germany ZEG:Germany ZEG:Germany ZEGA:Germany ZEG:Germany A1ZN34:Brazil

Address

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA

Website

https://www.astrazeneca.com

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.